The Cox model was adjusted on the randomization stratification factors with background therapy at baseline, age, sex, DaT-SPECT contralateral putamen binding ratio at baseline
GLP-1 medications such as semaglutide and tirzepatide have transformed the way obesity and weight management are approached
It seems that weight loss will likely be very important for the benefits of the GLP-1 medicines in some conditions, and much less important, or not at all essential, for benefits in other disorders. According to Lane, although GLP-1 receptor agonists show promise in reducing cardiovascular risk factors, long-term cardiovascular safety trials are needed to assess cardiovascular mortality and events
Approximately 1 in 200 Americans have Graves' disease, an autoimmune condition that speeds metabolism and creates unique challenges for weight management
This is how our own researchers would approach the task